Article Details
Retrieved on: 2022-04-01 14:08:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Accutar Biotechnology Announces First Patient Dosed with AC0176 in Phase 1 Study in Patients with Metastatic Castration-Resistant Prostate Cancer ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here